Novo seeks to ramp up investments in medtech, hospitals

Novo Holdings, which controls obesity drugmaker Novo Nordisk, is sharpening its focus on India, targeting single-specialty hospitals and contract drugmakers to tap highgrowth healthcare segments, according to a senior company executive.

- Reuters

Patients in the world's most populous nation are increasingly preferring specialised amenities, which some analysts and industry insiders say will form the bedrock of demand in the Indian healthcare market. The sector is also booming with increasing private and foreign investments.